Sun, Mar 1, 2015, 4:58 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • wilderguide wilderguide Jun 21, 2013 12:49 PM Flag

    Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

    From the June 2013 NEJM...peer reviewed reporting on PFE's NCT00932893.
    "Conclusion: Crizotinib is superior to standard chemotherapy in patients with pre-treated advanced NSCLC with ALK rearrangement (ALK +)

    It appears likely that Crizotinib will replace chemo in advanced ALK+ NSCLC. Should this label expansion take place, ganetespib will likely catch a ride on Crizo's coattails with it 's known capacity to reverse Crizo-induced resistance. If the PFS translates to extended OS in the ongoing combo trial, G is a shoe-in...JMHO

2.40-0.020(-0.83%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Aruba Networks, Inc.
NASDAQFri, Feb 27, 2015 4:00 PM EST
Vulcan Materials Company
NYSEFri, Feb 27, 2015 4:00 PM EST